Taken together, our findings indicated that the expression of Slit2/Robo1 axis possibly be regarded as a significant clinical parameter for predicting intention of brain metastasis in breast cancer patients and probably contributes to providing a new therapeutic target for patients with brain metastasis. This evidence concerns the gene ROBO1 and breast carcinoma.